MTOR and diabetes mellitus: We also evaluated the expression of SIRT-3 and p-mTOR in non-cancerous adjacent liver tissue of HCC patients with diabetes and/or metabolic syndrome, to verify whether their positive expression was limited to cancerous tissue.